Table I.
A, Cluster 1 | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Incidencea | Mortalitya | ||||||||||||
Population | M | F | M and F | M | F | M and F | Life expectancy Year 2015 M and Fb | Screening programmec | Regionsc | Testc–g | Age targetc–g | Screening Intervalc–g | Payment Policyc–g |
Uzbekistan | 5.6 | 4.9 | 5.3 | 3.9 | 3.3 | 3.9 | 68.5 | Unknown | NR | NA | NR | NR | NR |
Outside European | |||||||||||||
Institutions | |||||||||||||
Tajikistan | 7.3 | 4.0 | 5.5 | 5.1 | 2.8 | 3.6 | 69.8 | Unknown | NR | NR | NR | NR | NR |
Outside European | |||||||||||||
Institutions | |||||||||||||
Azerbaijan | 7.1 | 6.4 | 6.7 | 4.3 | 4.0 | 4.6 | 70.8 | Spontaneous | NR | iFOBT | NR | NR | NR |
Outside European | |||||||||||||
Institutions | |||||||||||||
Kyrgyzstan | 8.1 | 8.3 | 8.2 | 5.7 | 5.8 | 4.1 | 70.7 | Unknown | NR | NA | NR | NR | NR |
Outside European | |||||||||||||
Institutions | |||||||||||||
Albania | 9.0 | 7.9 | 8.4 | 4.8 | 3.9 | 5.8 | 78.0 | Unknown | NR | NA | NR | NR | NR |
Georgia | 9.9 | 7.5 | 8.5 | 5.5 | 4.0 | 5.7 | 74.8 | Organized, NPB | All nation | gFOBT | 50–69 | 2 | Free of charge |
Turkmenistan | 9.3 | 9.0 | 9.0 | 6.0 | 5.7 | 4.4 | 65.7 | Not organized | NR | iFOBT | NR | NR | NR |
Outside European | |||||||||||||
Institutions | |||||||||||||
Greece | 16.3 | 11.2 | 13.5 | 9.2 | 6.1 | 13.7 | 81.6 | Spontaneous | All nation | FOBT | 50–70 | 2 | NR |
Turkey | 20.5 | 13.1 | 16.6 | 12.6 | 7.8 | 7.5 | 75.4 | Organized, PB | All nation | FOBT | 50–69 | 2 | Free of charge |
Bosnia and | 20.7 | 13.3 | 16.6 | 12.7 | 7.7 | 11.1 | 76.6 | Organized, | Regional | FOBT | >50 | NR | NR |
Herzegovina | PB spontaneous | All nation | FOBT | >50 | |||||||||
Armenia | 22.8 | 17.0 | 19.3 | 13.4 | 9.7 | 9.8 | 74.8 | Spontaneous | NR | iFOBT | NR | NR | NR |
B, Cluster 2 | |||||||||||||
Incidencea | Mortalitya | ||||||||||||
Population | M | F | M and F | M | F | M and F | Life expectancy Year 2015 M and Fb | Screening programmec | Regionsc | Testc–g | Age targetc–g | Screening Intervalc–g | Payment Policyc–g |
Kazakhstan | 29.1 | 19.4 | 22.8 | 16.9 | 10.7 | 10.0 | 72.0 | Organized, PB | All nation | FOBT | 50–70 | 2 | NA |
Outside European | |||||||||||||
Institutions | |||||||||||||
Ukraine | 29.9 | 19.8 | 23.4 | 18.8 | 10.8 | 14.5 | 71.2 | Unknown | NR | NA | NR | NR | NR |
Lithuania | 31.2 | 18.9 | 23.4 | 19.7 | 10.2 | 13.7 | 75.1 | Spontaneous, | All nation | iFOBT | 50–74 | 2 | Free of |
NPB | charge | ||||||||||||
Finland | 28.2 | 19.7 | 23.5 | 10.2 | 6.9 | 10.4 | 81.4 | Organized, PB | All nation | FOBT | 50–69 | 2 | Free of |
charge | |||||||||||||
Latvia | 30.0 | 20.2 | 23.7 | 17.7 | 10.4 | 15.9 | 74.1 | Spontaneous, | All nation | gFOBT | >50 | 2 | Free of |
NPB | charge | ||||||||||||
FRY of Macedonia Belarus | 28.4 | 20.5 | 24.3 | 15.5 | 10.8 | 13.4 | 75.5 | Unknown | NR | FOBT | NR | NR | NR |
Outside European | |||||||||||||
Institutions | 30.9 | 20.7 | 24.4 | 17.5 | 10.4 | 12.8 | 73.6 | Not organized | NR | NR | NR | NR | NR |
Russian Federation | 30.0 | 21.8 | 24.5 | 19.9 | 12.6 | 9.9 | 70.9 | Organized | St. Petersburg region | iFOBT | 48–75 | 2 | NR |
Outside European | |||||||||||||
Institutions | |||||||||||||
Cyprus | 27.3 | 22.2 | 24.5 | 8.6 | 5.3 | 13.0 | 80.3 | Organized, PB | All nation | gFOBT | >50 | Once | Free of |
Organized, PB | All nation | Coloscopy | >55 | Once | charge | ||||||||
Austria | 34.0 | 19.6 | 26.0 | 13.3 | 7.2 | 16.6 | 81.8 | Spontaneous, | All nation | iFOBT | >50 | 2 | Insurance |
NPB | Coloscopy | 10 | Copayment | ||||||||||
Romania | 34.5 | 20.2 | 26.4 | 18.2 | 9.7 | 12.9 | 75.0 | Unknown | NR | NA | NR | NR | NR |
Poland | 37.2 | 19.5 | 27.0 | 20.6 | 10.3 | 12.9 | 78.2 | Organized, PB | All nation | Colonoscopy | 50–66 | 10 | Free of |
charge | |||||||||||||
Estonia | 35.1 | 22.6 | 27.2 | 17.6 | 9.4 | 15.2 | 77.1 | Organized, PB | All nation | FOBT | 50–74 | 2 | Free of |
charge | |||||||||||||
Montenegro | 36.2 | 21.1 | 28.2 | 20.7 | 12.0 | 11.2 | 76.3 | Unknown | NR | NA | NR | NR | NR |
Republic of Moldova | 36.0 | 23.0 | 28.3 | 22.0 | 12.6 | 8.3 | 71.6 | Spontaneous | NR | iFOBT | NR | NR | NR |
Bulgaria | 40.0 | 25.1 | 31.5 | 21.3 | 12.0 | 12.3 | 74.5 | Spontaneous | NR | iFOBT Coloscopy | NR | NR | NR |
Serbia | 43.4 | 23.3 | 32.6 | 22.8 | 11.5 | 9.3 | 75.5 | Organized, PB | All nation | iFOBT | 50–74 | 2 | Free of charge |
Croatia | 44.2 | 24.7 | 32.9 | 26.7 | 13.0 | 18.0 | 77.3 | Organized, PB | All nation | gFOBT | 50–74 | 2 | Free of charge |
C, Cluster 3 | |||||||||||||
Incidencea | Mortalitya | ||||||||||||
Population | M | F | M and F | M | F | M and F | Life expectancy Year 2015 M and Fb | Screening programmec | Regionsc | Testc–g | Age targetc–g | Screening Intervalc–g | Payment Policyc–g |
Ireland | 43.1 | 27.7 | 34.9 | 16.0 | 8.9 | 16.5 | 81.5 | Organized, PB | All nation | iFOBT | 55–74 | 2 | Free of charge |
Israel | 43.0 | 30.3 | 35.9 | 12.6 | 10.0 | 10.7 | 82.1 | Organized, PB | All nation | iFOBT | 50–74 | 2 | Free of charge |
Outside European | |||||||||||||
Institutions | |||||||||||||
Belgium | 45.2 | 29.5 | 36.7 | 14.7 | 9.5 | 13.4 | 81.3 | Organized, PB | Regional | gFOBT | 50–74 | 2 | Free of charge |
Slovenia | 49.7 | 27.0 | 37.0 | 22.9 | 11.2 | 16.2 | 81.1 | Organized, PB | All nation | iFOBT | 50–69 | 2 | Free of charge |
Czech Republic | 54.0 | 27.1 | 38.9 | 22.6 | 9.9 | 16.0 | 79.5 | Spontaneous, | All nation | gFOBT | 50–54 | 1 | Insurance |
NPB | gFOBT | >55 | 2 | Copayment | |||||||||
Coloscopy | 10 | ||||||||||||
Norway | 42.6 | 35.8 | 38.9 | 14.2 | 12.1 | 14.5 | 82.1 | Organized, PB | Regional | iFOBT | 55–64 | 2 | Free of charge |
Netherlands | 47.5 | 33.9 | 40.2 | 16.0 | 11.2 | 13.0 | 81.7 | Organized, PB | All nation | iFOBT | 55–75 | 2 | Free of charge |
Denmark | 45.9 | 37.5 | 40.5 | 16.8 | 12.5 | 20.8 | 81.1 | Organized, PB | All nation | gFOBT | 50–74 | 2 | Free of charge |
Hungary | 58.9 | 30.5 | 42.3 | 30.1 | 14.5 | 15.4 | 76.0 | Organized, PB | All nation | iFOBT | 50–70 | 2 | Free of charge |
Slovakia Republic | 61.6 | 29.3 | 42.7 | 26.9 | 12.0 | 12.3 | 77.2 | Spontaneous, NPB | All nation | Coloscopy | >50 | 2 | Free of charge |
D, Cluster 4 | |||||||||||||
Incidencea | Mortalitya | ||||||||||||
Population | M | F | M and F | M | F | M and F | Life expectancy Year 2015 M and Fb | Screening programmec | Regionsc | Testc–g | Age targetc–g | Screening Intervalc–g | Payment Policyc–g |
Iceland | 29.9 | 28.2 | 28.4 | 9.3 | 5.8 | 6.9 | 82.9 | Spontaneous, but programmed as organized | All nation | iFOBT | 55–75 | 2 | Free of charge |
Sweden | 32.3 | 26.5 | 29.2 | 12.2 | 9.7 | 7.4 | 82.6 | Organized, PB | Regional | gFOBT | 60–69 | 2 | Free of charge |
Switzerland | 36.3 | 23.6 | 29.4 | 12.8 | 6.4 | 12.2 | 83.2 | Spontaneous | All nation | iFOBT | 50–70 | 2 | Insurance |
Coloscopy | 10 | Copayment | |||||||||||
France (Metrop.) | 36.1 | 24.9 | 30.0 | 12.9 | 8.0 | 10.8 | 82.7 | Organized, PB | All nation | FOBT | 50–74 | 2 | Free of charge |
United Kingdom | 36.8 | 24.4 | 30.2 | 13.0 | 8.7 | 13.6 | 82.0 | Organized, PB | All nation | gFOBT | 50–74 | 2 | Free of charge |
Germany | 39.7 | 23.3 | 30.9 | 13.1 | 8.1 | 11.8 | 81.1 | Spontaneous, | All nation | gFOBT | 50–54 | 1 | Insurance |
NPB | gFOBT | >55 | 2 | Copayment | |||||||||
Coloscopy | 10 | ||||||||||||
Luxembourg | 42.1 | 21.6 | 31.5 | 13.9 | 8.8 | 12.2 | 82.2 | Spontaneous, NPB | All nation | iFOBT | 55–74 | 2 | Free of charge |
Portugal | 41.8 | 23.6 | 31.7 | 19.0 | 9.4 | 10.2 | 81.5 | Organized, PB | Regional | FOBT | 50–70 | 2 | Free of charge |
Malta | 39.9 | 25.2 | 31.9 | 14.5 | 10.4 | 18.7 | 81.9 | Organized, PB | All nation | iFOBT | 60–64 | 2 | Free of charge |
Spain | 43.9 | 24.2 | 33.1 | 17.1 | 8.4 | 10.9 | 83.4 | Organized, PB | All nation | iFOBT | 50–69 | 2 | Free of charge |
Italy | 41.5 | 27.5 | 33.9 | 13.5 | 8.6 | 11.1 | 83.5 | Organized, PB | All nation | iFOBT | 50–70 | 2 | Free of |
Coloscopy | 58 or 60 | Once | Charge | ||||||||||
Andorra | NR | NR | NR | NR | NR | NR | NR | NR | NR | iFOBT Coloscopy | NR | NR | NR |
Monaco | NR | NR | NR | NR | NR | NR | NR | NR | All nation | iFOBT | 50–80 | 2 | Free of charge |
San Marino | NR | NR | NR | NR | NR | NR | NR | NR | All nation | iFOBT | 50–79 | 2 | Free of charge |
Ferlay J. Soerjomataram I. Dikshit R. Eser S. Mathers C. Rebelo M. Parkin DM. Forman D. Bray F. Int J Cancer. 2015Mar1;136(5):E359-86. GLOBOCAN 2012 http://globocan.iarc.fr/Default.aspx: Last Accessed: December 23. 2016.
Data Available from WORLD BANK OPEN DADA database; URL https://data.worldbank.org/. Last accessed 1 September 2017.
Altobelli E. Lattanzi A. Paduano R. Varassi G. di Orio F. Colorectal cancer prevention in Europe: burden of disease and status of screening programs. Prev Med 2014;62:132-141.
Schreuders EH. Ruco A. Rabeneck L. Schoen RE. Sung JJ. Young GP. Kuipers EJ. Colorectal cancer screening: A global overview of existing programmes. Gut 2015;64(10):1637-1649.
Giordano L. Bisanti L. Salamina G. Ancelle Park R. Sancho-Garnier H. Espinas H. Berling C. Rennert G. Castagno R. Dotti M. Jaramillo L. Segnan N. The EUROMED CANCER network: state-of-art of cancer screening programmes in non-EU Mediterranean countries. Eur J Public Health 2016;26(1):83-89.
https://ec.europa.eu/health/sites/health/files/major_chronic_diseases/docs/2017_cancerscreening_2ndreportimplementation_en.pdf. Cancer Screening in the European Union (2017). Report on the implementation of the Council Recommendation on cancer screening. Cancer Screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening. Reprint May 2017. NR, Not Reported; PB, Population Based; NPB, Non Population Based; M, Male; F, Female.